PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bioland Laboratory, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People\'s Republic of China.\', \'Savaid Medical School, University of Chinese Academy of Science, Beijing, People\'s Republic of China.\', \'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People\'s Republic of China.\', \'Guangzhou Institute of Infectious Disease, Guangzhou Eighth People\'s Hospital, Guangzhou Medical University, Guangzhou, People\'s Republic of China.\', \'Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, People\'s Republic of China.\', \'iRepertoire Inc. , Huntsville, AL, USA.\', \'College of Life Sciences and Chemistry, Hunan University of Technology, Zhuzhou, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/22221751.2021.1925594
?:doi
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 33944697
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all